Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reusser

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Schweizerische Medizinische Wochenschrift|April 16, 1998
[Pulmonary tuberculosis with resistance to 4 antitubercular drugs]S Reichlin, R Frei, P Reusser
Schweizerische Medizinische Wochenschrift|October 19, 1996
[Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact]P Reusser, B Hostettler, R Attehbofer
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Treatment of pediatric bacterial meningitis with a 7-day regimen of once-daily ceftriaxone injections. Multicentre study carried out in non-university pediatric departments in the French and Italian-speaking regions of SwitzerlandF Renevey, E Martin, F Fröscher, et al.
Revue Medicale De La Suisse Romande|August 1, 1988
[The treatment of bacterial meningitis in children with a 7-day course of daily-dose ceftriaxone by injection. Multicenter study in the non-university pediatric services of French-speaking Switzerland and of Tessin]F Renevey, E Martin, R Fröscher, et al.
Acta Haematologica|January 1, 1987
Autoimmune hemolytic anemia associated with IgA--diagnostic and therapeutic aspects in a case with long-term follow-upP Reusser, B Osterwalder, H Burri, et al.
Reviews of Infectious Diseases|November 1, 1991
Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patientsS R Riddell, P Reusser, P D Greenberg
Praxis|June 20, 1998
[Chylothorax as the initial manifestation of malignant Hodgkin lymphoma]A Shalev, H Borer, P Reusser, et al.
The Journal of Infectious Diseases|July 9, 1999
Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus loadP Reusser, G Cathomas, R Attenhofer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1988
Hematological support in patients undergoing allogenetic bone marrow transplantationB Osterwalder, A Gratwohl, P Reusser, et al.
The Journal of Infectious Diseases|September 1, 1992
Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipientsP Reusser, J G Gambertoglio, K Lilleby, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Schweizerische Medizinische Wochenschrift|April 16, 1998
[Pulmonary tuberculosis with resistance to 4 antitubercular drugs]S Reichlin, R Frei, P Reusser
Schweizerische Medizinische Wochenschrift|October 19, 1996
[Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact]P Reusser, B Hostettler, R Attehbofer
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Treatment of pediatric bacterial meningitis with a 7-day regimen of once-daily ceftriaxone injections. Multicentre study carried out in non-university pediatric departments in the French and Italian-speaking regions of SwitzerlandF Renevey, E Martin, F Fröscher, et al.
Revue Medicale De La Suisse Romande|August 1, 1988
[The treatment of bacterial meningitis in children with a 7-day course of daily-dose ceftriaxone by injection. Multicenter study in the non-university pediatric services of French-speaking Switzerland and of Tessin]F Renevey, E Martin, R Fröscher, et al.
Acta Haematologica|January 1, 1987
Autoimmune hemolytic anemia associated with IgA--diagnostic and therapeutic aspects in a case with long-term follow-upP Reusser, B Osterwalder, H Burri, et al.
Reviews of Infectious Diseases|November 1, 1991
Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patientsS R Riddell, P Reusser, P D Greenberg
Praxis|June 20, 1998
[Chylothorax as the initial manifestation of malignant Hodgkin lymphoma]A Shalev, H Borer, P Reusser, et al.
The Journal of Infectious Diseases|July 9, 1999
Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus loadP Reusser, G Cathomas, R Attenhofer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1988
Hematological support in patients undergoing allogenetic bone marrow transplantationB Osterwalder, A Gratwohl, P Reusser, et al.
The Journal of Infectious Diseases|September 1, 1992
Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipientsP Reusser, J G Gambertoglio, K Lilleby, et al.
Pageof 6